Leuprolide Depot Injection Clinical Trials

• Study of a 6-Month Sustained-release Formulation of Leuprolide in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00056654 - Completed
  Prostatic Neoplasms
  
• Efficacy and Safety of Leuprolide Acetate 3.75 Mg Depot to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00128531 - Completed
  Prostate Cancer
  
• Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
  ClinicalTrials.gov Identifier: NCT00088465 - Active, not recruiting
  Schizophrenic Disorders
  
• Leuprolide or Goserelin Plus Thalidomide Compared With Leuprolide or Goserelin Alone in Treating Patients With Nonmetastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00020085 - Active, not recruiting
  Prostate Cancer
  
• Leuprolide in Treating Adults With Hypogonadotropism
  ClinicalTrials.gov Identifier: NCT00004438 - Recruiting
  Hypogonadism
  
• Leuprolide in Determining the Cause of Gonadotropin Deficiency
  ClinicalTrials.gov Identifier: NCT00004426 - Recruiting
  Hypogonadism
  
• Behavioral Naltrexone Therapy (BNT) for Promoting Adherence to Oral Naltrexone (BNT-Oral) vs Extended Release Injectable Depot Naltrexone (Depot-BNT); a Randomized Trial. A Free Treatment for Opiate Abuse.
  ClinicalTrials.gov Identifier: NCT00577408 - Recruiting
  Opiate Dependence; Heroin Dependence
  
• Oral and Depot Naltrexone - 1
  ClinicalTrials.gov Identifier: NCT00218426 - Recruiting
  Heroin Dependence
  
• RAD001 plus Depot Octreotide in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
  ClinicalTrials.gov Identifier: NCT00113360 - Active, not recruiting
  Carcinoma, Neuroendocrine; Carcinoid Tumor; Carcinoma, Islet Cell
  
• A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00275262 - Recruiting
  Hodgkin''s Disease, Non-Hodgkin''s Lymphoma, Multiple Myeloma
  
• Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088491 - Completed
  Schizophrenic Disorders
  
• Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate
  ClinicalTrials.gov Identifier: NCT00070369 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• The Use of Nutropin Depot in HIV-Infected Adult Males
  ClinicalTrials.gov Identifier: NCT00286676 - Active, not recruiting
  HIV Infection
  
• Primary Progesterone Therapy for Operable Breast Cancer
  ClinicalTrials.gov Identifier: NCT00123669 - Active, not recruiting
  Breast Neoplasms
  
• Phase II Randomized Study of Leuprolide vs Oral Contraceptive Therapy vs Leuprolide and Oral Contraceptive Therapy for Ovarian Hyperandrogenism
  ClinicalTrials.gov Identifier: NCT00004763 - Completed
  Hyperandrogenism
  
• Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00283062 - Recruiting
  Prostatic Neoplasms
  
• Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
  ClinicalTrials.gov Identifier: NCT00076440 - Completed
  Alzheimer Disease
  
• Clinical Trial for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00076531 - Active, not recruiting
  Prostate Cancer
  
• A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Subjects With a Rising PSA
  ClinicalTrials.gov Identifier: NCT00514917 - Recruiting
  Prostatic Neoplasms
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients with Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00116753 - Active, not recruiting
  Prostate Cancer
  
• Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
  ClinicalTrials.gov Identifier: NCT00458458 - Recruiting
  Endometriosis; Dysmenorrhea; Dyspareunia
  
• Comparison of Intramuscular Olanzapine Depot with Placebo in the Treatment of Patients with Schizophrenia
  ClinicalTrials.gov Identifier: NCT00088478 - Completed
  Schizophrenia
  
• Melanoma Vaccine With Peptides and Leuprolide
  ClinicalTrials.gov Identifier: NCT00254397 - Recruiting
  Melanoma
  
• Study of External Beam Radiation Therapy with and Without Hormonal Therapy to Treat Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00116220 - Active, not recruiting
  Prostate Cancer
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Efficacy and Safety Trial of ALK-Depot SQ Mites in Subjects With Atopic Dermatitis
  ClinicalTrials.gov Identifier: NCT00310492 - Recruiting
  Atopic Dermatitis
  
• Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
  Schizophrenia
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00430183 - Recruiting
  Prostate Cancer
  
• Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00498901 - Recruiting
  Breast Cancer
  
• STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
  ClinicalTrials.gov Identifier: NCT00050635 - Completed
  Neoplasms; Diarrhea
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003915 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Operable Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002580 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
  
• Insulin Resistance and Testosterone in Women with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00123110 - Recruiting
  Metabolic Syndrome; Postmenopause
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• Triptorelin for Ovary Protection in Childhood Onset Lupus
  ClinicalTrials.gov Identifier: NCT00124514 - Recruiting
  SLE; Systemic Lupus Erythematosus
  
• Clinical Trial of Leuprolide Acetate for the Treatment of PMS
  ClinicalTrials.gov Identifier: NCT00001259 - Recruiting
  Depressive Disorder; Mood Disorder
  
• Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028769 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• Evaluation of Efficacy and Safety of Long-Acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone
  ClinicalTrials.gov Identifier: NCT00563017 - Recruiting
  Schizophrenia, Catatonic; Schizophrenia, Disorganized; Schizophrenia, Paranoid; Schizophrenia; Psychotic Disorders
  
• Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
  ClinicalTrials.gov Identifier: NCT00094640 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002597 - Active, not recruiting
  stage II prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Hormone Therapy in Treating Patients Who Have Stage I or Stage II Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003645 - Active, not recruiting
  stage II prostate cancer; stage I prostate cancer
  
• Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002889 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002582 - Active, not recruiting
  stage II breast cancer; stage I breast cancer; stage IIIA breast cancer
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003394 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Sandostatin LAR® Depot in Patients with Primary Insulin Hypersecretion (PIH) and at least Moderate Obesity
  ClinicalTrials.gov Identifier: NCT00094146 - Completed
  Primary Insulin Hypersecretion; Obesity
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
  ClinicalTrials.gov Identifier: NCT00081159 - Active, not recruiting
  recurrent prostate cancer; stage IV prostate cancer; bone metastases
  
• Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003124 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002633 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00103376 - Recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• Efficacy of Gynodian® Depot in Women With Impaired Well-Being
  ClinicalTrials.gov Identifier: NCT00463450 - Completed
  Hormone Replacement Therapy
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients when given with an Experimental Injection Catheter
  ClinicalTrials.gov Identifier: NCT00090714 - Active, not recruiting
  Angina Pectoris
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction